Login

Adrian Jones, Senior Vice President for Asia Pacific and Japan at Oracle Corporation, highlights the innovations Oracle is driving in the tech industry. 00:10:00

Share On Facebook Share On Twitter

Oracle Japan's CEO is Toshimitsu Misawa, 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
AdvTech Reports Strong Financial Performance with 22% Revenue Growth and Dividend Declaration | Roy Douglas, CEO, Advtech Ltd .
00:10:00
Chris Maart on Morgate Management's Approach to Business Growth and Restructuring
00:10:00
In Conversation: Matt Brown & Blythe Masters on Finance Innovation and Blockchain
00:10:00
Fundamentals of Digital Asset Indexing: A Deep Dive into the MarketVector Token Terminal Index Suite
00:10:00
Get to Know Tim Schau: Syverson Strege Team | Tim Schau - IT Support Specialist of Syverson Strege
00:10:00
Lee Ainslie: From High School Investment Club to Hedge Fund Titan and Philanthropist|Lee Ainslie, Founder & Managing Partner,Maverick Capital
00:10:00
Interview with Darwin Green, CEO of HighGold: Project Update and Exploration Plans
00:10:00
Managing Director and Founder, Mr. Adam Bloomer, and Chief Executive Officer, Dr. Jessica North from LGI Ltd, presented at our latest Morgans event.
00:10:00
Ofelia Noblesala highlights her experience with skill development and role expansion within Astronics' opportunity-oriented culture.|Peter J. Gundermann is Chairman, President and Chief Executive Officer of Astronics Corp
00:00:00
Sensorion seeks partner for inner ear disorder drug - Nawal Ouzren, CEO, Sensorion
00:10:00
I'll Burn That Bridge When I Get to It: Essays on Identity Politics and Academic Freedom|Norman Finkelstein,Professor,Xavier University
00:10:00
Arctic Council's Commitment to Sustainable Development and Cooperation

© 2026 Nehu